Poisons Standard Amendment (Hydroxychloroquine and Salbutamol) Instrument 2020
I, Tony Gill, as delegate of the Secretary of the Department of Health, make the following instrument.
Dated 23 March 2020
Tony Gill
Principal Medical Adviser
Prescription Medicines Authorisation Branch
Health Products Regulation Group
Department of Health
Contents
2 Commencement
3 Authority
4 Schedules
Schedule 1—Amendments
Part 1—Hydroxychloroquine
Poisons Standard February 2020
Part 2—Salbutamol
Poisons Standard February 2020
This instrument is the Poisons Standard Amendment (Hydroxychloroquine and Salbutamol) Instrument 2020.
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | The day after this instrument is registered. | 24 March 2020 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
This instrument is made under paragraph 52D(2)(a) of the Therapeutic Goods Act 1989.
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Poisons Standard February 2020
1 Schedule 4 of Part 4 of Schedule 2 (entry for hydroxychloroquine)
Repeal the entry, substitute:
# HYDROXYCHLOROQUINE.
2 At the end of Appendix D of Part 5 of Schedule 2
Add:
8. | Poisons for which the initial treatment of a patient has been authorised following the commencement of the Poisons Standard Amendment (Hydroxychloroquine and Salbutamol) Instrument 2020 by a medical practitioner, recognised under State or Territory legislation that forms part of the Health Practitioner Regulation National Law, as a specialist in any of the following specialties: (a) dermatology; (b) intensive care medicine; (c) paediatrics and child health; (d) physician; (e) emergency medicine. |
| HYDROXYCHLOROQUINE. |
3 Schedule 2 (index)
Omit the entry for hydroxychloroquine, substitute:
HYDROXYCHLOROQUINE
Schedule 4
Appendix D, Item 8
Poisons Standard February 2020
4 Schedule 3 of Part 4 of Schedule 2 (entry for salbutamol)
Repeal the entry, substitute:
SALBUTAMOL as the only therapeutically active substance:
a) in metered aerosols delivering 100 micrograms or less of salbutamol per metered dose; or
b) in dry powders for inhalation delivering 200 micrograms or less of salbutamol per dose; and
where supply is limited:
c) to persons with evidence of a medically diagnosed lung condition; or
d) to persons with a record of previous supply from the pharmacist; or
e) to persons authorised under a law of a State or Territory to use or supply salbutamol in the practice of their profession; or
f) for use in institutional first aid; and
where paragraph (c) or (d) applies—supply is limited to one primary pack of salbutamol per person.